Company intelligence / Profile preview

Apira Science

Irvine, California, United Statesapirascience.com ↗

Ownership: Private
Development stage: Commercial

Overview

Apira Science developed the iGrow Hair Growth Platform, a hands-free, home-use low-level laser therapy device for treating androgenetic alopecia. The system is FDA-cleared and has demonstrated clinical effectiveness in promoting hair growth in men with male pattern baldness. It is also cleared by regulatory agencies in Brazil and several Asian countries for consumer use at home.

Therapeutic areas: Dermatology
Modalities: DeviceNon-pharmacological therapyLow-level laser therapy (LLLT)
Industry: Therapeutic Medical Devices

Drug pipeline

2 assets

iGrow

Commercial

Indications: Alopecia, Hair loss

1 more asset in the full pipeline.

Request access →

Partnerships

Onderma (Brazilian distribution partner)

Beyond the preview

Go deeper on Apira Science.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Apira Science.

Explore the full profile